Professional Documents
Culture Documents
the internal auditory artery, supplies the CN VIII complex in the subarachnoid space and
follows it into the internal auditory canal. Along the course of the BA (basiller artery), small perforators
arise directly to supply portions of the pons and midbrain. The median perforators of
the BA supply the medial longitudinal fasciculus, the paramedian pontine formation, and
the medially located nuclei of CN s III, IV, and VI. Interruption of these branches ( which
occurs commonly with vertebrobasilar atherosclerotic disease or emboli to these endarteries)
often produces variable ophthalmoplegia, internuclear ophthalmoplegia, and skew
deviation. Pontine branches of the BA also supply the proximal portions of the cranial
nerves (particularly CN V) as they exit the brainstem.
In the context of eye movement control, an "internuclear" lesion is one that disrupts the
medial longitudinal fasciculus (MLF), a bundle of fibers that connects the sixth nerve nucleus
on one side of the pons to the medial rectus sub nucleus ( of the third nerve) on the contralateral side of the
mid brain ( see Chtpter 1, Fig 1- 28). This type oflesion produces
an internuclear ophthalmoplegia (INO).
Orbital Myositis
Idiopathic inflammation of I or more extraocular muscles typically produces ophthalmoplegia
and pain, often with conjunctiva! hyperemia, chemosis, and sometimes proptosis.
The pain may be quite intense and is accentuated by eye movements. If the inflammation
is confined to the posterior orbit, the eye may appear to be white and quiet. Results of CT
or MRI typically show enlargement of 1 or more of the extraocular muscles with tendon
involvement, and the inflammation often extends into the orbital fat. Orbital myositisrelated
pain usually responds within 24 hours to systemic corticosteroid therapy, whereas
diplopia may take longer to resolve. Orbital myositis is usually an isolated phenomenon
but may be part of a systemic disease such as Wegener granulomatosis (ie, granulomatosis
with polyangiitis), systemic lupus erythematosus, or sarcoidosis (see also Chapter 14 and
BCSC Section 7, Orbit, Eyelids, and Lacrimal System).